Please login to the form below

Not currently logged in
Email:
Password:

Three directors join UK’s MHRA

Valerie Beral, Alexander Markham and David Webb join UK regulatory body

The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has named three new non-executive directors.

Valerie Beral, MHRA

Dame Valerie Beral, Prof Sir Alexander Markham and Prof David Webb will all join the board of the MHRA, which regulates the safety of medicines and medical devices in the UK.

Dame Valerie (pictured right) is director of the cancer epidemiology unit at the University of Oxford, where her research has included reproductive, hormonal and infectious agents in cancer.

She also helped lead the Million Women Study, which helped demonstrate that hormone replacement therapy increases a woman's risk of developing breast cancer.

Prof Markham is professor of medicine at the University of Leeds and a former CEO of the charity Cancer Research UK.

He is also director of the molecular medicine unit at St James's University Hospital and chairman of the NHS Connecting for Health Research Capability Programme, in addition to serving on a number of panels of the Medical Research Council.

David Webb, MHRA

Prof Webb (pictured left) is Christison professor of therapeutics and clinical pharmacology at the University of Edinburgh.

His research has focused on internal medicine, hypertension and cardiovascular risk management, and he established Edinburgh University's Wellcome Trust cardiovascular research initiative and centre for cardiovascular science.

In addition to his academic role, he is the current leader of the Scottish Translational Medicine and Therapeutics Initiative (STMTI), established by the Wellcome Trust.

“I'm delighted that Dame Valerie, Sir Alex and Professor Webb have accepted appointments as non-executive directors of the MHRA,” said Sir Gordon Duff, chair of the MHRA.

“They will bring highly relevant experience and expertise to our board at a time of significant development of the Agency, and will contribute importantly to our strategic leadership.

30th July 2013

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

The era of digital wellbeing
Social media - friend or foe?...
World Mental Health Day 2019: Employment and Mental Illness
Mednet Group's white paper with a focus on navigating the world of work is available online in aid of World Mental Health Day 2019....
Changing direction
Changing direction: adapting to a rapidly-evolving environment
Chris Ross examines why creative partnerships could be key to commercial success in today’s healthcare marketplace...

Infographics